New WHO Guideline on Testing of Counterfeit Medicines

The World Health Organization (WHO) has published a new guideline that describes the procedure for checking supposedly counterfeit or suspect medicines.

The WHO distinguishes three types of "Suspect Medicines":

  • "Out of specification" medicines
  • Unregistered/unlicensed medicines
  • Medicines that have been deliberately falsified.

The present guideline deals mainly with the third category. It contains technical assistance for sampling, laboratory testing of supposedly falsified medicinal products and the corresponding reporting. Examples of this can be found in the appendix of the document for

  • Analysis methods for package identification
  • An information collection form
  • Content of a SOP for testing counterfeit tablets
  • Flowcharts for the review procedure (decision tree)

Please visit the WHO website for the new WHO guidance testing of "suspect" falsified medicines.

Go back


Stay informed with the GMP Newsletters from ECA

GMP Newsletter

The ECA offers various free of charge GMP newsletters for which you can subscribe to according to your needs.

To subscribe, please click here.